医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集

遺伝学

Telix Pharmaceuticals and Applied Radiology Launch TelixU Medical Education Platform Focused on Radiopharmaceutical Research

Telix Pharmaceuticals and Applied Radiology Launch TelixU Medical Education Platform Focused on Radiopharmaceutical Research

その他ヘルスバイオテクノロジーヘルスケア外科放射線学腫瘍学製薬遺伝学　 TimeLine: Telix Pharmaceuticals and Applied Radiology Launch TelixU Medical Education Platform Focused on Radiopharmaceutical Research

2021年06月14日

Valemetostat Data at EHA Shows Promising Durable Tumor Response in Patients with Peripheral T-Cell Lymphoma and Adult T-Cell Leukemia/Lymphoma

Valemetostat Data at EHA Shows Promising Durable Tumor Response in Patients with Peripheral T-Cell Lymphoma and Adult T-Cell Leukemia/Lymphoma

バイオテクノロジーヘルスケア腫瘍学臨床試験製薬遺伝学　 TimeLine: Lymphoma Valemetostat Data at EHA Shows Promising Durable Tumor Response in Patients with Peripheral T-Cell Lymphoma and Adult T-Cell Leukemia

2021年06月11日

Shoreline Biosciences and BeiGene Announce Strategic Worldwide Collaboration to Develop and Commercialize Genetically Modified Natural Killer (NK) Cell Therapies

Shoreline Biosciences and BeiGene Announce Strategic Worldwide Collaboration to Develop and Commercialize Genetically Modified Natural Killer (NK) Cell Therapies

バイオテクノロジーヘルスケア幹細胞腫瘍学製薬遺伝学　 TimeLine: Cell Therapies NK Shoreline Biosciences and BeiGene Announce Strategic Worldwide Collaboration to Develop and Commercialize Genetically Modified Natural Killer

2021年06月09日

Patritumab Deruxtecan Data at ASCO Demonstrates Tumor Response Across Multiple Resistance Mechanisms in Patients with Advanced EGFR-Mutated NSCLC

Patritumab Deruxtecan Data at ASCO Demonstrates Tumor Response Across Multiple Resistance Mechanisms in Patients with Advanced EGFR-Mutated NSCLC

バイオテクノロジーヘルスケア腫瘍学臨床試験製薬遺伝学　 TimeLine: Patritumab Deruxtecan Data at ASCO Demonstrates Tumor Response Across Multiple Resistance Mechanisms in Patients with Advanced EGFR-Mutated NSCLC

2021年06月04日

Veristat Appoints Colleen Pelton Chief Talent Officer

Veristat Appoints Colleen Pelton Chief Talent Officer

バイオテクノロジーヘルスケア医療機器幹細胞感染症腫瘍学臨床試験製薬遺伝学　 TimeLine: Veristat Appoints Colleen Pelton Chief Talent Officer

2021年06月02日

ERSゲノミクス：日本特許庁がシャルパンティエ／ダウドナの重要CRISPR特許を支持し、第3の特許を認める

ERSゲノミクス：日本特許庁がシャルパンティエ／ダウドナの重要CRISPR特許を支持し、第3の特許を認める

バイオテクノロジーヘルスケア医療機器製薬遺伝学　 TimeLine: ERSゲノミクスシャルパンティエダウドナ特許重要CRISPR特許

2021年06月02日

Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand

ヘルスケアヘルス一般医療機器遺伝学　 TimeLine: Illumina and Next Generation Genomic Partner to Launch VeriSeq NIPT Solution in Thailand

2021年06月01日

Available Now! Whitepaper: Advancing Drug Discovery Through DNA Encoded Library Technology!

Available Now! Whitepaper: Advancing Drug Discovery Through DNA Encoded Library Technology!

バイオテクノロジーヘルスケア製薬遺伝学　 TimeLine: Advancing Drug Discovery Through Available Now DNA Encoded Library Technology Whitepaper

2021年05月28日

Engine Biosciences Announces $43 Million Series A Round to Decipher Genetic Codes for New Medicines Through Machine Learning and Next-Generation Combinatorial Genetics

Engine Biosciences Announces $43 Million Series A Round to Decipher Genetic Codes for New Medicines Through Machine Learning and Next-Generation Combinatorial Genetics

バイオテクノロジーヘルスケア腫瘍学製薬遺伝学　 TimeLine: $43 Million Series A Round to Decipher Genetic Codes for New Medicines Through Machine Learning and Next-Generation Combinatorial Genetics Engine Biosciences Announces

2021年05月26日

Engine Biosciences宣布获得超额认购的4300万美元A轮融资，以通过机器学习和新一代组合遗传学破译新药开发遗传密码

Engine Biosciences宣布获得超额认购的4300万美元A轮融资，以通过机器学习和新一代组合遗传学破译新药开发遗传密码

バイオテクノロジーヘルスケア腫瘍学製薬遺伝学　 TimeLine: Engine Biosciences宣布获得超额认购的4300万美元A轮融资机器学习和新一代组合遗传学破译新药开发遗传密码

2021年05月26日